(1)
Amend, C.; Weinmann, M.; Amberger, D. C.; Schwepcke, C.; Doraneh-Gard, F.; Krämer, D. M.; Schmid, C.; Rank, A.; Schmetzer, H. M. Induced Antileukemic Activity After Blast Modulation Is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells. acbr 2025, 9, 521-541.